Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Interhermispheric inhibition predicts anxiety levels in multiple sclerosis: A corticospinal excitability study.

Chalah MA, Palm U, Lefaucheur JP, Créange A, Ayache SS.

Brain Res. 2018 Nov 15;1699:186-194. doi: 10.1016/j.brainres.2018.08.029. Epub 2018 Aug 30.

PMID:
30172702
2.

The ulnar ratio as a sensitive and specific marker of acute inflammatory demyelinating polyneuropathy.

Ahdab R, Noureldine MHA, Mohammedi K, Nader M, Zouari HG, Nordine T, Créange A, Lefaucheur JP, Ayache SS.

Clin Neurophysiol. 2018 Aug;129(8):1699-1703. doi: 10.1016/j.clinph.2018.05.017. Epub 2018 Jun 11.

PMID:
29940481
3.

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Hachulla E, Le Masson G, Solé G, Hamidou M, Desnuelle C, Azulay JP, Besson G, Swiader L, Abad S, Antoine JC, Bouhour F, Créange A, Grenouillet M, Magy L, Marcel S, Paquet JM, Rouhart F, Ziegler F, Mathis S, Gauthier-Darnis M, Puget S.

Biomed Res Int. 2018 Mar 15;2018:8147251. doi: 10.1155/2018/8147251. eCollection 2018.

4.

Human Endogenous Retroviruses in Neurological Diseases.

Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, Giovannoni G, Hartung HP, Perron H.

Trends Mol Med. 2018 Apr;24(4):379-394. doi: 10.1016/j.molmed.2018.02.007. Epub 2018 Mar 15. Review.

5.

The evaluation of depression in multiple sclerosis using the newly proposed Multiple Sclerosis Depression Rating Scale.

Palm U, Chalah MA, Créange A, Lefaucheur JP, Ayache SS.

Encephale. 2018 Feb 17. pii: S0013-7006(18)30001-0. doi: 10.1016/j.encep.2017.11.004. [Epub ahead of print]

PMID:
29463384
6.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
7.

Theory of mind in multiple sclerosis: A neuropsychological and MRI study.

Chalah MA, Kauv P, Lefaucheur JP, Hodel J, Créange A, Ayache SS.

Neurosci Lett. 2017 Sep 29;658:108-113. doi: 10.1016/j.neulet.2017.08.055. Epub 2017 Aug 31.

PMID:
28855125
8.

Adenosine Triphosphate Metabolism Measured by Phosphorus Magnetic Resonance Spectroscopy: A Potential Biomarker for Multiple Sclerosis Severity.

Kauv P, Ayache SS, Créange A, Chalah MA, Lefaucheur JP, Hodel J, Brugières P.

Eur Neurol. 2017;77(5-6):316-321. doi: 10.1159/000475496. Epub 2017 May 4.

PMID:
28467982
9.

Effects of left DLPFC versus right PPC tDCS on multiple sclerosis fatigue.

Chalah MA, Riachi N, Ahdab R, Mhalla A, Abdellaoui M, Créange A, Lefaucheur JP, Ayache SS.

J Neurol Sci. 2017 Jan 15;372:131-137. doi: 10.1016/j.jns.2016.11.015. Epub 2016 Nov 10.

PMID:
28017199
10.

Guillain-Barré syndrome: 100 years on.

Créange A.

Rev Neurol (Paris). 2016 Dec;172(12):770-774. doi: 10.1016/j.neurol.2016.10.011. Epub 2016 Nov 17. Review.

PMID:
27866731
11.

Loss of immune tolerance to IL-2 in type 1 diabetes.

Pérol L, Lindner JM, Caudana P, Nunez NG, Baeyens A, Valle A, Sedlik C, Loirat D, Boyer O, Créange A, Cohen JL, Rogner UC, Yamanouchi J, Marchant M, Leber XC, Scharenberg M, Gagnerault MC, Mallone R, Battaglia M, Santamaria P, Hartemann A, Traggiai E, Piaggio E.

Nat Commun. 2016 Oct 6;7:13027. doi: 10.1038/ncomms13027.

12.

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Faucard R, Madeira A, Gehin N, Authier FJ, Panaite PA, Lesage C, Burgelin I, Bertel M, Bernard C, Curtin F, Lang AB, Steck AJ, Perron H, Kuntzer T, Créange A.

EBioMedicine. 2016 Apr;6:190-198. doi: 10.1016/j.ebiom.2016.03.001. Epub 2016 Mar 10.

13.

Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.

Ayache SS, Palm U, Chalah MA, Al-Ani T, Brignol A, Abdellaoui M, Dimitri D, Sorel M, Créange A, Lefaucheur JP.

Front Neurosci. 2016 Apr 8;10:147. doi: 10.3389/fnins.2016.00147. eCollection 2016.

14.

Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis.

Palm U, Chalah MA, Padberg F, Al-Ani T, Abdellaoui M, Sorel M, Dimitri D, Créange A, Lefaucheur JP, Ayache SS.

Restor Neurol Neurosci. 2016;34(2):189-99. doi: 10.3233/RNN-150557.

PMID:
26890095
15.

Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.

Sørensen PS, Sellebjerg F, Lycke J, Färkkilä M, Créange A, Lund CG, Schluep M, Frederiksen JL, Stenager E, Pfleger C, Garde E, Kinnunen E, Marhardt K; RECYCLINE Study Investigators.

Eur J Neurol. 2016 May;23(5):861-70. doi: 10.1111/ene.12953. Epub 2016 Feb 5.

PMID:
26848561
16.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

17.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS.

J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29.

PMID:
26810539
18.

Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.

Ayache SS, Al-ani T, Farhat WH, Zouari HG, Créange A, Lefaucheur JP.

Neurophysiol Clin. 2015 Dec;45(6):475-84.

PMID:
26776079
19.

Cortical excitability changes over time in progressive multiple sclerosis.

Ayache SS, Créange A, Farhat WH, Zouari HG, Lesage C, Palm U, Abdellaoui M, Lefaucheur JP.

Funct Neurol. 2015 Oct-Dec;30(4):257-63.

20.

Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.

Chalah MA, Riachi N, Ahdab R, Créange A, Lefaucheur JP, Ayache SS.

Front Cell Neurosci. 2015 Nov 30;9:460. doi: 10.3389/fncel.2015.00460. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center